Chongqing Xishan Science & Technology Co., Ltd. (SHA:688576)

China · Delayed Price · Currency is CNY

37.07

+0.78 (2.15%)

At close: Jul 31, 2026

SHA:688576 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	347.94	341.99	336.38	360.69	262.27	208.86
Revenue Growth	6.06%	1.67%	-6.74%	37.52%	25.57%	63.97%
Gross Profit	210.3	210.22	233.43	247.34	179.02	145.47
Operating Income	22.59	26	65.33	90.38	62.7	49.75
Net Income	47.72	51.91	98.67	117.34	75.35	61.43
Earnings Per Share	0.73	0.77	1.32	1.70	1.28	1.12
EPS Growth	-36.55%	-41.62%	-22.14%	33.16%	13.92%	265.34%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Medical Instruments	337.02
Other	4.05
Total	341.06

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	694.9	725.1	993.02	1,586	332.89	304.24
Total Debt	-	-	0.13	3.09	6.17	9.43
Net Cash (Debt)	694.9	725.1	992.89	1,583	326.72	294.8
Net Cash Growth	-22.93%	-26.97%	-37.29%	384.60%	10.82%	194.20%
Net Cash Per Share	10.59	10.78	13.30	22.91	5.53	5.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	58.96	60.03	39.47	68.08	79.1	55.88
Capital Expenditures	-79.68	-96	-157.55	-103.72	-49.15	-14.18
Free Cash Flow	-20.72	-35.96	-118.08	-35.64	29.95	41.7
Free Cash Flow Growth	-	-	-	-	-28.17%	26.18%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	60.44%	61.47%	69.39%	68.57%	68.26%	69.65%
Operating Margin	6.49%	7.60%	19.42%	25.06%	23.91%	23.82%
Pretax Margin	13.55%	15.52%	33.11%	35.23%	28.48%	29.13%
Profit Margin	13.71%	15.18%	29.33%	32.53%	28.73%	29.41%
FCF Margin	-5.96%	-10.51%	-35.10%	-9.88%	11.42%	19.96%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.336	0.336	0.671	0.671
Dividend Per Share Growth	-25.50%	-49.99%	0%	-
Dividend Yield	0.91%	0.80%	1.65%	1.08%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	50.99	54.81	27.30	43.42	-	-
Forward PE	-	17.59	18.32	33.49	-	-
PS Ratio	7.17	8.32	8.01	14.13	-	-